4.2 Article

Imatinib Mesylate Has The Potential to Exert Its Efficacy by Down-Regulating The Plasma Concentration of Platelet-Derived Growth Factor in Patients With Pulmonary Arterial Hypertension

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Respiratory System

Imatinib mesylate inhibits fibrogenesis in asbestos-induced interstitial pneumonia

Kirsi Vuorinen et al.

EXPERIMENTAL LUNG RESEARCH (2007)

Article Medicine, Research & Experimental

Reversal of experimental pulmonary hypertension by PDGF inhibition

RT Schermuly et al.

JOURNAL OF CLINICAL INVESTIGATION (2005)

Letter Medicine, General & Internal

Imatinib for the treatment of pulmonary arterial hypertension

HA Ghofrani et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Immunology

Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis

A Abdollahi et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2005)

Review Medicine, General & Internal

Drug therapy: Treatment of pulmonary arterial hypertension

M Humbert et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)